Submitted by Anonymous (not verified) on 4 March 2026 - 14:36
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised